Physician profile
Alison Mcafee
NPI 1407064637
$917.89
in general payments reported to CMS, 2019-2025
16 companies · $44.08 in 2025
The $44.08 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $135 · 2020: $80.94 · 2021: $201 · 2022: $147 · 2023: $192 · 2024: $119 · 2025: $44.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $354.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $168.91 | 2019-2023 | Bexsero |
| Merck Sharp & Dohme LLC | $133.66 | 2019-2025 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Sanofi Pasteur INC. | $123.69 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $118.22 | 2019-2022 | |
| Seqirus USA INC | $70.15 | 2022-2025 | Flucelvax Quadrivalent, Flucelvax |
| Sanofi-Aventis U.S. LLC | $59.34 | 2024 | |
| Genentech USA, INC. | $56.64 | 2019-2021 | |
| Pfizer INC. | $46.53 | 2023-2024 | |
| Abbott Laboratories | $25.13 | 2022 | |
| Ironshore Pharmaceuticals INC. | $22.27 | 2019 | |
| Sobi, INC | $18.98 | 2019 | |
| Alk-Abello, INC | $15.69 | 2023 | Grastek, Odactra, Ragwitek |
| Neos Therapeutics, LP | $15.56 | 2021 | |
| Tris Pharma INC | $15.10 | 2021 | |
| Kaleo, INC. | $14.28 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $13.74 | 2024 | Flumist Quadrivalent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Mcafee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.